NewYorkBIO

NewYorkBIO is thrilled to announce that Jak Knowles will be presenting at the Life Science Company Showcase at the New York Stock Exchange on December 9, 2024! This is a fantastic opportunity for investors to engage with companies making cutting-edge advancements in healthcare and life sciences. Companies, including Affini-T Therapeutics will present groundbreaking insights and scientific innovation that shapes the future for better health outcomes. Do not miss this unique chance to witness a scientifically captivating presentation and connect with leading minds in biosciences. Investors and finance professionals are welcome to join us at the NYSE to discover where innovation meets investment potential! Request registration here (https://lnkd.in/e2kWSNmK) #NewYorkBIO #LifeScienceShowcase #NYBIO #BiotechInnovation #InvestInScience #NYSE

NewYorkBIO is thrilled to announce that Tessa Callaghan will be presenting at the Life Science Company Showcase at the New York Stock Exchange on December 9, 2024 This is a fantastic opportunity for investors to engage with companies making cutting-edge advancements in healthcare and life sciences. Companies, including Keel Labs will present groundbreaking insights and scientific innovation that shapes the future for better health outcomes. Do not miss this unique chance to witness a scientifically captivating presentation and connect with leading minds in biosciences. Investors and finance professionals are welcome to join us at the NYSE to discover where innovation meets investment potential! Request registration here (https://lnkd.in/e2kWSNmK). #NewYorkBIO #LifeScienceShowcase #NYBIO #BiotechInnovation #InvestInScience #NYSE

NewYorkBIO is thrilled to announce that Jessica Ballinger will be presenting at the Life Science Company Showcase at the New York Stock Exchange on December 9, 2024! This is a fantastic opportunity for investors to engage with companies making cutting-edge advancements in healthcare and life sciences. Companies, including Lyndra Therapeutics will present groundbreaking insights and scientific innovation that shapes the future for better health outcomes. Do not miss this unique chance to witness a scientifically captivating presentation and connect with leading minds in biosciences. Investors and finance professionals are welcome to join us at the NYSE to discover where innovation meets investment potential! Request registration here (https://lnkd.in/e2kWSNmK). #NewYorkBIO #LifeScienceShowcase #NYBIO #BiotechInnovation #InvestInScience #NYSE

Last week, NewYorkBIO cohosted a networking reception with Crowell & Moring at their wonderful office. The event included a captivating fireside chat moderated by Linda Malek, partner in the Healthcare and Privacy/Cybersecurity practices at Crowell in discussion with Andrew Lam, Managing Director and Head of Biotech Private Equity, Ally Bridge Group and Prem Premsrirut, Founder and CEO, Mirimus Inc. and Executive Director of Micoy Therapeuticsm focused on how to approach investing and raising funds during this election cycle.    If you missed it, don’t worry our Life Science Company Showcase is right around the corner: https://lnkd.in/eDy9cmeP

Early bird registration closes next week on October 31st for the NewYorkBIO Holiday Reception! Join us for our annual event on the iconic NYSE trading floor in heart of New York's Financial District. Use the link below to register: https://lnkd.in/eAkpv-uM

In case you missed it: NewYorkBIO’s CEO Jennifer Hawks Bland represented NewYorkBIO earlier this week at Governor Hochul’s announcement highlighting the new State-of-the-Art Cell and Gene Therapy Hub at Northwell Health. This investment marks a transformative moment for New York's life science ecosystem and will undoubtedly accelerate breakthrough treatments for cancer and serious diseases while driving economic growth across our region. We extend our sincere appreciation to Governor Hochul and all partners involved in making New York a premier destination for life science innovation.

Today is a historic day for New York’s life science community as we celebrate Governor Hochul's announcement of a new State-of-the-Art Cell and Gene Therapy Hub. This Hub, in close proximity to Northwell Health, will undoubtedly position New York as a national leader in Cell and Gene Therapies, demonstrating the power of collaboration between New York’s academic medical and life science communities, including NewYorkBIO members such as New York Blood Center who was present at today’s announcement - all in pursuit of transforming medical research and advancing lifesaving treatments for cancer and other serious diseases.    Beyond the development of Cell and Gene Therapies, this Hub will also drive unparalleled opportunities for economic development across the region. NewYorkBIO looks forward to supporting and welcoming the companies and advancements that this Hub will produce, as we continue to lead efforts to solidify New York’s status as a worldwide leader in the life sciences.   For more information about the investment, visit Governor Hochul’s newsroom: https://lnkd.in/g6fgeeQU

Today is the last day to register for our networking event with Crowell & Moring this Thursday, October 24 between 5:30 and 7:30 pm. We will kick off the evening with a fireside chat moderated by Linda A. Malek, partner in the Healthcare and Privacy/Cybersecurity practices at Crowell in discussion with Andrew W. Lam, PharmD, Managing Director and Head of Biotech Private Equity, Ally Bridge Group and Prem Premsrirut, Founder and CEO, Mirimus Inc. and Executive Director of Micoy Therapeutics. Priority Registration is given to invited guests and NewYorkBIO members. Registration will be closed at 7:00 pm EST today! Use the link below to register! https://lnkd.in/eB7yAb7k

We are excited to host a networking event with Crowell & Moring next week on October 24 between 5:30 and 7:30 pm. We will kick off the evening with a fireside chat moderated by Linda Malek, partner in the Healthcare and Privacy/Cybersecurity practices at Crowell in discussion with Andrew W. Lam, PharmD, Managing Director and Head of Biotech Private Equity, Ally Bridge Group and Prem Premsrirut, Founder and CEO, Mirimus Inc. and Executive Director of Micoy Therapeutics. Priority Registration is given to invited guests and NewYorkBIO members. Use the link below to register! https://lnkd.in/eB7yAb7k